Records containing: Neurofibromatosis Type 2
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase I Trial of Bevacizumab, Temsirolimus Alone and in Combination With Valproic Acid, or Cetuximab in Patients With Advanced Malignancy and Other Indications
-
CLINICAL_TRIALS study record update · 2026-01-12Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
-
CLINICAL_TRIALS study record update · 2025-12-08Doxycycline Injection of Cutaneous Schwannoma in Neurofibromatosis Type 2
-
CLINICAL_TRIALS study record update · 2025-10-07A Two-staged, Phase 2/3, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of REC-2282 in Participants With Progressive NF2 Mutated Meningiomas
-
CLINICAL_TRIALS study record update · 2024-02-13A Single Arm, Monocenter Phase II Trial of RAD001 as Monotherapy in the Treatment of Neurofibromatosis Type 2 - Related Vestibular Schwannoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-05-11Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma
-
CLINICAL_TRIALS study record update · 2021-12-01Phase II Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
-
CLINICAL_TRIALS study record update · 2021-09-09Icotinib Hydrochloride Tablets Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
-
CLINICAL_TRIALS study record update · 2021-01-22Phase II Trial of Bevacizumab in Patients With Recurrent or Progressive Meningiomas
-
CLINICAL_TRIALS study record update · 2020-05-27Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
-
CLINICAL_TRIALS study record update · 2020-05-13Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas
-
CLINICAL_TRIALS study record update · 2020-03-17The Effect of Changes in Head Position on Magnetic Resonance Image Distortion in Patients With Auditory Implants
-
CLINICAL_TRIALS study record update · 2019-12-06Compassionate Use Arm - ABI541 Auditory Brainstem Implant for Neurofibromatosis Type 2 Patients With Deafness
-
CLINICAL_TRIALS study record update · 2018-07-23Whole Exome Sequencing (WES) of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data
-
CLINICAL_TRIALS study record update · 2017-08-17Phase 2 Study of Bevacizumab in Children and Adults With Neurofibromatosis Type 2 and Symptomatic Vestibular Schwannoma
-
CLINICAL_TRIALS study record update · 2017-02-09Recombinant Human Endostatin Injection Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors by Continuous Intravenous Pumping